Publications

Disease Burden and Unmet Medical Need in Patients With Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey

Published on: Value in Health
Authors: George Gourzoulidis, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Charalampos Tzanetakos,

Authors:OBJECTIVES: Ulcerative colitis (UC) requires life-long disease management. The study objective was to investigate the burden of UC and unmet medical need in patients who receive advanced (biologic or JAK inhibitor) therapy in Greece. METHODS: Between October...

Read More

Treatment Preferences of Patients With Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey

Published on: Value in Health
Authors: George Gourzoulidis, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Petros Savourdos, Charalampos Tzanetakos, ,

Abstract:OBJECTIVES: The real-world efficacy of the available therapies can be considerably influenced by the patient preferences. This study objective was to investigate treatment preferences for ulcerative colitis (UC) patients who receive advanced therapies in...

Read More

Treatment Preferences of Patients With Crohn’s Disease in Greece: A Cross-Sectional Patient Survey

Published on: Value in Health
Authors: Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Petros Savourdos, George Gourzoulidis, ,

Abstract: OBJECTIVES: As patient preference data become an important component of treatment decision making, this study objective was to investigate treatment preferences for Crohn’s disease (CD) patients who receive advanced therapies in Greece. METHODS: Between...

Read More

Disease Burden and Unmet Medical Need in Patients With Crohn’s Disease in Greece: A Cross-Sectional Patient Survey

Published on: Value in Health
Authors: Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, George Gourzoulidis, ,

Abstract: OBJECTIVES: Crohn’s disease (CD) requires life-long disease management. The study objective was to investigate the burden of CD and unmet medical need in patients who receive biologic therapy in Greece. METHODS: Between October 2023 and January 2024, adult...

Read More

Cost-Effectiveness Analysis of Epcoritamab for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy in Greece

Published on: Value in Health
Authors: Charalampos Tzanetakos, George Papageorgiou, A Wang, Marina Psarra, George Gourzoulidis, ,

Abstract:OBJECTIVES: To estimate the cost-effectiveness of epcoritamab compared to available treatment alternatives for treating relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after at least two lines of systemic therapy in Greece. METHODS: A...

Read More

Archive per Year